London Stock Exchange Group Reports Income Growth Fueled by Tradeweb Lenovo Shares Surge Over 15 After Record Earnings as AI Revenue Nearly Doubles Satellites and AI Deployed to Track UK Hedgehog Decline Highlighting Environmental Monitoring Opportunities SP 500 Notches Gains as Healthcare and Tech Lead Communication Services Slips Traders Now See Next Fed Interest Rate Move as a Hike Following Inflation Surge Micron Technology Surge Propels US Stocks to Record Highs Report Says LION Q1 2026 Earnings Strong EPS Surprise of 5296 Drives Stock Rally UG Q2 2025 Earnings Profitability Maintained Amid Modest Stock Reaction MarineMax Inc Q1 2026 Earnings EPS Miss Mirrors Challenging Boating Environment BJDX Q4 2023 Earnings EPS Falls Far Below Estimates Revenue Remains Absent Sensient Technologies SXT Q1 2026 Earnings Strong EPS Surprise Drives Stock Gain Bakkt Q1 2026 Earnings Significant EPS Miss Amid Ongoing Operational Challenges Titan Acquisition Corp Units TACHU Hold Steady at 1045 as Trading Activity Remains Muted Ingevity NGVT Edges Higher Amid Quiet Trading Holds Above Key Support Willow Lane Acquisition Corp Unit WLACU Surges 77 Key Levels and What May Come Next FinVolution Group FINV Tumbles 6 Key Support and Resistance Levels Under Scrutiny Agenus AGEN Rallies 22 Biotech Momentum Faces Key Resistance at 356 Stellantis Turnaround Plan Prediction Market Regulation Oura IPO Filing Key Market Developments ATXG Q1 2025 Earnings Loss per Share of 025 and Stock Decline Highlight Ongoing Challenges Balchem Corporation BCPC Holds Steady at 16175 Consolidation in a Tight Range First Bancorp FBNC Gains Ground as Regional Bank Sector Sees Renewed Optimism American Battery Technology Company ABAT Holds Near Support Amid Modest Gains BlackRock Taxable Municipal Bond Trust BBN Posts Minor Gain Hovers Between Support and Resistance VisionWave Holdings VWAV Edges Lower Testing Key Support Zone Near 500 Intelligent Bio Solutions INBS Climbs 44 as Shares Test Key Resistance Near 271 Jyong Biotech Ltd MENS Shows Resilience Uptick from Key Support Zone Corvus Pharmaceuticals CRVS Climbs 230 as Shares Approach Resistance